Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by sleeveenon Jan 21, 2015 2:30pm
239 Views
Post# 23344954

Patent Dispute

Patent Dispute
I realize that the dispute between GE Healthcare Bio Sciences and Prometic Life Sciences has been ongoing for a considerable period of time.  I'm not overly concerned about this issue because respected investors like Robert McWhirter are so supportive of PLI. However, i would appreciate hearing from posters such as francois21, or sah1, or bepando on how they view this apparently unresolved issue. See brief court summary at: 

https://www.ippractice.ca/file-browser/?fileno=T-1046-12
Bullboard Posts